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Abstract
Background: Historically, inpatient protocols have adopted relatively conservative approaches to refeeding in
Anorexia Nervosa (AN) in order to reduce the risk of refeeding syndrome, a potentially fatal constellation of
symptoms. However, increasing evidence suggests that patients with AN can tolerate higher caloric prescriptions
during treatment, which may result in prevention of initial weight loss, shorter hospital stays, and less exposure to
the effects of severe malnutrition. Therefore the present study sought to examine the effectiveness of a more
accelerated refeeding protocol in an inpatient AN and atypical AN sample.
Methods: Participants were youth (ages 10–22) with AN (n = 113) and atypical AN (n = 16) who were hospitalized
for medical stabilization. A retrospective chart review was conducted to assess changes in calories, weight status
(percentage of median BMI, %mBMI), and indicators of refeeding syndrome, specifically hypophosphatemia, during
hospitalization. Weight was assessed again approximately 4 weeks after discharge.
Results: No cases of refeeding syndrome were observed, though 47.3 % of participants evidenced hypophosphatemia
during treatment. Phosphorous levels were monitored in all participants, and 77.5 % were prescribed supplemental
phosphorous at the time of discharge. Higher rates of caloric changes were predictive of greater changes in %mBMI
during hospitalization. Rates of caloric and weight change were not related to an increased likelihood of re-admission.
Conclusions: Results suggest that a more accelerated approach to inpatient refeeding in youth with AN and atypical
AN can be safely implemented and is not associated with refeeding syndrome, provided there is close monitoring and
correction of electrolytes. These findings suggest that this approach has the potential to decrease length of stay and
burden associated with inpatient hospitalization, while supporting continued progress after hospitalization.
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Plain English Summary
Anorexia Nervosa (AN) has been shown to be the dead-
liest mental disorder due to the serious medical and psy-
chiatric problems that are associated with this illness.
Many hospital treatment programs start patients with
AN on low calorie diets and increase their meal plans
gradually. It has been thought that this approach reduces
the chance of patients having refeeding syndrome, a
potentially fatal complication that can happen when
severely underweight individuals begin to eat more.
However, a gradual approach to refeeding prolongs
hospitalization and causes more disruption for patients
and families. Our study examined a refeeding program
that started patients with AN and atypical AN on higher
calorie meal plans and advanced their calories more rap-
idly than traditional approaches to inpatient hospital
treatment. Results showed that this protocol was related
to increased weight gain, but was not related to re-
admission or refeeding syndrome. Our findings support
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a more rapid approach to refeeding patients with AN
and atypical AN in the hospital.
Background
Children and adolescents with eating disorders may re-
quire inpatient hospitalization for medical stabilization
and weight regain [1–3], with Anorexia Nervosa (AN)
accounting for a significant proportion of such admis-
sions [4]. Higher rates of weight gain and higher weight
status upon discharge are generally predictive of better
outcomes and weight maintenance after inpatient treat-
ment [5–7]. Despite the importance of early weight
changes in long-term recovery from AN, current na-
tional standards in the U.S. recommend relatively
conservative approaches to refeeding in AN (e.g.,
starting at 1200 calories and increasing by 200 calories
every other day) [8, 9].
Such “start low, go slow” approaches were developed
with the aim of reducing the risk of refeeding syndrome,
a potentially fatal condition that may occur when nutri-
tion is re-introduced to a severely malnourished individ-
ual. Although there are no strict definitions, refeeding
syndrome is characterized by a constellation of symp-
toms stemming from shifts in electrolytes that may
occur when refeeding malnourished individuals, which
can lead to potentially lethal complications [10–12].
Early signs of refeeding syndrome include low levels of
serum phosphorous, magnesium or potassium. Refeed-
ing syndrome may cause serious clinical complications
including signs of fluid shifts (e.g., edema), respiratory
distress, congestive heart failure, cardiac arrhythmias,
and seizures [13]. This condition is a serious risk during
refeeding and has been documented in reports of AN
treatment [14].
Hypophosphatemia has emerged as a clear marker of
risk of refeeding syndrome, and the central role of
phosphorous during refeeding is well-described [15].
The risk of refeeding hypophosphatemia also appears to
be greatest for patient’s presenting with more severe
malnutrition [15, 16]. Per the recent review by Garber
and colleagues [16], replacing phosphorus has not been
associated with adverse side effects. Despite the general
consensus and recommendation to monitor and replace
phosphorous during nutritional rehabilitation of mal-
nourished patients, there are not clear guidelines for
how to replace phosphorous, especially with more accel-
erated refeeding protocols. At our center, hospitalists re-
place phosphorous when it is declining, thereby possibly
avoiding hypophosphatemia and preventing refeeding
syndrome.
Although the “start low, go slow” approach to refeed-
ing attempts to minimize risk of refeeding syndrome,
this approach also has significant downsides, in that it
incurs more cost and burden to families, and in some
studies has been shown to result in initial weight loss
and slower rates of weight gain while during
hospitalization [17]. These findings are particularly im-
portant in light of altered metabolic processes that have
been documented in AN. That is, while individuals with
AN demonstrate reduced metabolic rate [18], evidence
suggests that during the refeeding process they become
energy inefficient due to hypermetabolism and increased
dietary-induced thermogenesis (i.e., energy production
caused by metabolizing food consumed) [19–21], which
may persist following weight restoration [2]. This is also
evidenced by the fact that individuals with AN require
more energy per kilogram of body weight than would be
expected for normal weight individuals to gain weight
[20, 22]. Therefore it is necessary to develop safe,
evidence-based refeeding protocols that account for this
phenomenon and provide adequate energy intake levels
to accomplish ample weight regain early in treatment.
Furthermore, there is emerging evidence to suggest
that hospitalized individuals with AN can tolerate more
aggressive refeeding protocols, which is contrary to
“start low, go slow” approaches [16, 23]. This is consist-
ent with recently published Australian and New Zealand
guidelines recommending a less conservative refeeding
approach in conjunction with appropriate monitoring
and supplementation of phosphorus [24]. Indeed, some
studies of adolescents with AN have shown that higher
calorie prescriptions and more rapid weight gain are not
related to hypophosphatemia or other signs of refeeding
syndrome [25–30]. Moreover, higher calories prescribed
upon admission have been found to relate to shorter
lengths of stay [17, 25, 26], which has the potential to in-
crease the cost-effectiveness of treatment and reduce
burden and disruption associated with hospitalization.
Evidence also suggests that higher initial calories pre-
dict higher rates of weight gain [25], yet some research
has not replicated this finding [26]. In addition, it is not
clear whether higher rates of weight gain are necessarily
beneficial for patients’ long-term outcomes. While one
study of adolescent and adult inpatients treated for AN
found that higher rates of weight restoration were pre-
dictive of higher weight at 1-year follow-up [7], in an-
other inpatient sample, more rapid weight gain was
found to predict higher rates of re-hospitalization [31].
Additionally, in adolescents, some studies have found
that weight status at admission and discharge was not
related to clinical outcomes [32, 33].
Despite some variations between studies, a previous
synthesis of studies of more rapid refeeding approaches
to refeeding in AN summarized the evidence for the
“start high, advance fast” approach to refeeding in AN
patients (at 75–85 % of median Body Mass Index,
%mBMI) in hospital as (1) beginning at 1500 kcal or
higher; (2) advancing by 250 kcal every day or every
Smith et al. Journal of Eating Disorders  (2016) 4:35 Page 2 of 11
other day to reach 2500–3000 kcal by day 14; (3) weekly
weight gain of approximately 1.5 kg (3.3 lbs); (4) a lack
of indicators of refeeding syndrome; and (5) achieving
medical stability by approximately day 14 [34]. However,
a recent review of refeeding protocols by Garber and
colleagues [16] revealed that only seven studies thus far
have examined higher calorie meal-based protocols,
leaving much unknown about specific factors that influ-
ence patients’ weight gain during hospital stay and their
continued weight restoration post-discharge. Further-
more, thus far only one RCT has compared different ap-
proaches to refeeding [35]. This study, which assessed
young adults with a duration of illness of 3–4 years who
had been previously hospitalized, compared a protocol
consisting of nasogastric tube feedings plus meals to
meals alone [35]. Thus, there have been no RCTs compar-
ing different meal-based approaches to refeeding in chil-
dren and adolescents during their first hospitalization. In
the absence of such RCTs, retrospective studies have the
potential to provide further insight into the effectiveness
and acceptability of more rapid refeeding protocols.
Therefore, the present study sought to examine the
safety and effectiveness of a more accelerated meal-
based refeeding protocol for youth with AN and atypical
AN who were treated on an inpatient unit. It was pre-
dicted that (1) this protocol would result in significant
increases in weight status (%mBMI) without the occur-
rence of refeeding syndrome; (2) higher rates of caloric
change throughout treatment would be related to greater
change in %mBMI during and after hospitalization; (3)
higher rates of caloric and %mBMI change during hos-
pital stay would not be related to an increased likelihood
of re-hospitalization; and (4) higher calories prescribed
upon discharge would be predictive of greater %mBMI
increase between the time of discharge and follow-up
assessment.
Methods
Study design and participants
A retrospective chart review was conducted for consecu-
tive admissions of patients (ages 22 and younger) with a
primary diagnosis of AN or atypical AN1 who were
treated in the inpatient medical stabilization unit for
eating disorders at Children’s Hospitals and Clinics of
Minnesota from 2012 to 2015. Only first episodes of in-
patient hospitalization at this facility were included in
the analyses. Admission and discharge criteria are de-
scribed in Table 1. Admissions were based on clinical
evaluation and the requirement to meet at least one
admission criteria, which were based on previously
established guidelines in the U.S.[1, 3]. Readiness for dis-
charge was assessed by a team of hospitalists and eating
disorder specialists, including psychiatrists, psycholo-
gists, and social workers. Patients were deemed ready for
discharge when they showed improvement in vital signs
and electrolytes, had adequate oral intake for weight re-
gain, reached at least 75 % mBMI, had completed at
least one therapist-led family meal and one family-led
practice meal, and had an outpatient treatment plan in
place. Participants who started outpatient treatment
after discharge completed a follow-up assessment ap-
proximately 4 weeks after discharge. Data was not avail-
able for participants who did not follow-up in our
facility. Participants were excluded from analyses if they
received nasojejunal (NJ) or nasogastric (NG) tube feed-
ing during treatment, as they did not follow the same
refeeding protocol. No participants were excluded due
to co-occurring medical or psychiatric conditions. This
study was approved by the Institutional Review Board at
Children’s Hospitals and Clinics of Minnesota.
Refeeding protocol
The refeeding protocol consisted of three meals and two
snacks (afternoon and evening). Meals and snacks were
consumed in a supervised group dining room on the
unit. If participants were unable to consume the food
provided on their tray, they were offered a meal replace-
ment (i.e., high-calorie liquid supplement) that provided
an equivalent amount of energy. Participants were super-
vised by program staff for 60 min after meals and
30 min after snacks. In addition to meals, participants
Table 1 Inpatient admission and discharge criteria
Admission criteria Discharge criteria
Weight <75 % of median BMI (%mBMI) Medical stabilization
Rapid weight loss, even if weight not
<75 %
Admission criteria are no
longer met
Acute food refusal Adequate oral intake for
weight regain
Heart rate <50 bpm Cessation of vomiting
Orthostatic hypotension (increase in pulse
of >20 bpm or drop in blood pressure of
10–20 mmHg/min from supine to standing)
Has completed 1 staff led












Lack of improvement/worsening symptoms
despite outpatient treatment
Uncontrolled vomiting or hematemesis
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attended three groups per week on topics including
emotional regulation, problem solving and interpersonal
effectiveness/communication. Participants received add-
itional services including music therapy, child life pro-
gramming, physical therapy, and integrative medicine.
Participants were typically on telemetry for up to the
first 72 h following admission, or longer until their heart
rate trends were approaching 50 beats per minute. While
on telemetry, participants were required to remain on
the unit. Following this, if participants were finishing
meals they were allowed privileges such as going off the
unit (within the hospital grounds) with parents or
hospital staff. On the medical unit, bathrooms were not
locked and participants were not given additional
replacements if they were found to be engaging in exer-
cise. Participants were under staff supervision for the
majority of the day and into the evening, with additional
support requested from parents if needed. Participants
were required to be completing most meals and replace-
ments to attend physical therapy groups, which occurred
several times per week.
Most participants started on a 1500 kcal per day regi-
men. Calorie increases were made in 500 kcal incre-
ments in order to attain an inpatient rate of weight
regain of 130–200 g per day. The program included
collaborative weighing sessions twice weekly, in which
progress with weight regain was discussed openly with
the patient and family. The macronutrient composition
of the diet consisted of 50–60 % carbohydrate, 20–30 %
fat, and 15–20 % protein. Fluid requirements were calcu-
lated for each participant based on his/her current
weight using the Holliday-Segar Method [36]. Intraven-
ous (IV) fluids were administered if participants exhib-
ited significant signs of dehydration, hypotension, and/or
uncontrolled vomiting, or as otherwise clinically indi-
cated. Daily fluid intake and urine output were recorded
throughout hospitalization. Standard laboratory values
were taken upon admission, and most were repeated at
discharge. Electrolytes, including phosphorus, were
checked at least twice weekly. While there are few data on
inpatient supplementation protocols during refeeding for
patients with AN [37], given our accelerated meal-based
refeeding protocol, phosphorus was replaced frequently
with the goal of maintaining a level of 4.0 mg/dL. Two
formulations of phosphorus were utilized, including
Neutra-Phos tablets and K-Phos Neutral tablets or
packets.
Data collection
Chart reviews were conducted to extract assessments of
vital signs, laboratory values, and weight status during
hospitalization. Follow-up weight status was assessed at
participants’ 4-week follow-up in the outpatient clinic,
where Family-Based Treatment (FBT) [38] or Cognitive
Behavioral Therapy-Enhanced (CBT-E) [39] were offered
as first-line treatments. Re-admission to the inpatient
unit within 4 weeks of discharge was documented. While
it was not possible to verify whether patients were ad-
mitted to another facility, Children’s is the only hospital
in the region specializing in the medical stabilization of
pediatric patients with eating disorders.
Indicators of refeeding syndrome
Given the difficulties of quantifying all of the symptoms
that comprise refeeding syndrome, it has been recom-
mended that refeeding hypophosphatemia (i.e., serum
phosphorus level below 3 mg/dL) be considered as an
indicator of risk of refeeding syndrome [15]. Consistent
with this guideline, this study evaluated risk of refeeding
syndrome by assessing refeeding hypophosphatemia at
any time during hospitalization. Chart reviews were also
conducted for all participants to assess for the presence
of full refeeding syndrome. In addition, hospitalists
working in this unit consider the occurrence of multiple
electrolyte imbalances during refeeding, specifically
hypophosphatemia, hypokalemia, and hypomagnesemia,
to be indicative of a high likelihood of full refeeding syn-
drome. Given this practice, in order to quantitatively
operationalize a high likelihood of full refeeding syn-
drome, we also evaluated whether any participants evi-
denced all three of these electrolyte abnormalities during
their treatment (but not necessarily concurrently).
Statistical methods
Weight status was calculated based on the participant’s
age, height, sex, and corresponding Centers for Disease
Control and Prevention (CDC) 50th percentile BMI-for-
age [40], which is the expected median BMI among
normally developing adolescents of similar age, sex, and
height. Participant’s weight status was expressed as a
percentage of this value (%mBMI). The Estimated Energy
Requirement (EER) of each participant was calculated
retrospectively [41], which approximates the energy intake
required to maintain weight in a healthy individual of
similar age, sex, weight, and height at a low activity level
(Daily PAL: 1.0). Given that the EER underestimates the
energy needs of those with AN, EER was calculated
based on the BMI corresponding to the CDC median
BMI for age and sex, which is in line with previous
research [25].
Caloric changes were calculated both as raw values
and as percentages of participants’ EER in order to as-
sess the degree of energy surplus that was provided rela-
tive to their EER. The rate of caloric change during
treatment was calculated by dividing the change in calo-
ries between admission and discharge by their length of
stay, expressed in kcal/day.
Smith et al. Journal of Eating Disorders  (2016) 4:35 Page 4 of 11
Growth curve models were used to assess the nature
of change in %mBMI over time, and predictors of
%mBMI change were subsequently added to these
models using Hierarchical Linear Modeling (HLM) [42].
First, unconditional growth curve models investigated
whether there was a linear or nonlinear change over
time, which included both linear (π1i) and quadratic (π2i)
growth parameters, e.g.:
Level-1 Model
%mBMIti ¼ π0i þ π1i  Timetið Þ þ π2i  Timetið Þ2
þ eti
Level-2 Model
π0i ¼ β00 þ r0i
π1i ¼ β10 þ r1i
π2i ¼ β20 þ r2i
Given that it is likely that the rate of weight gain
varied between the time of hospitalization and post-
hospitalization, a piecewise linear growth model also
estimated growth rates separately during hospitalization
(admission to discharge) and post-hospitalization (dis-
charge to follow-up). Time-varying (level 1) and person-
level (level 2) predictors were subsequently added to
models to assess the relationship between the rate of
caloric change and %mBMI change during and after
hospitalization. In these conditional models, the rate of
caloric change was entered at level 1, while age and EER
were entered at level 2. In the model assessing post-
hospitalization %mBMI, discharge calorie level was also
entered as a predictor. A Bernoulli model assessed
whether higher rates of caloric and %mBMI change were
related to an increased likelihood of re-hospitalization
after discharge (binary outcome).
To evaluate the safety of the refeeding protocol, the
number and percentage of participants who evidenced
refeeding hypophosphatemia was assessed, as well as
whether any cases met the aforementioned criteria for
refeeding syndrome. A binary logistic regression model
also assessed predictors (i.e., admission %mBMI, age,
and rates of %mBMI and caloric changes) of hypopho-
sphatemia at any point during treatment. Analyses were
conducted using SPSS 24 [43] and HLM 7.01 [44].
Results
Sample characteristics
Table 2 displays characteristics of the sample. Eleven
participants were excluded from analyses because they
had NG/NJ tubes at some point during their treatment,
which resulted in a total sample of 129. Participants
were predominately female (94.6 %) and ranged in age
from 10 to 22 (M = 15.84, SD = 2.37). Most identified as
non-Hispanic Caucasian (89.1 %), and the remaining as
Asian American (3.9 %), African American (1.6 %), His-
panic/Latino (1.6 %), American Indian/Alaskan 0.8 %),
and multiracial (0.8 %). Three participants (2.3 %) did
not report this information. There were five participants
for which admission %mBMI could not be calculated be-
cause their age exceeded the maximum age specified in
CDC BMI-for-age charts. These participants were ex-
cluded from analyses involving %mBMI estimations. Of
the total sample, 113 (87.6 %) patients had AN, and 16
(12.4 %) had atypical AN.
Of the 129 participants, 12 (9.3 %) were re-admitted
within 4 weeks, and 89 (69.0 %) completed the 4-week
follow-up. Using an adjusted significance level for mul-
tiple comparisons (p < .01), participants who did and did
not complete follow up did not evidence significant dif-
ferences in admission %mBMI (t[122] = 1.41, p = .162),
discharge %mBMI (t[122] = 1.37, p = .175), length of stay
(t[127] = .511, p = .610), rate of caloric change (t[127] =
1.80, p = .074), age (t[127] = 2.11, p = .036), or proportion
of males compared to females (χ2 [1] =1.97, p = .160).
Safety and effectiveness
Laboratory values upon admission, during treatment,
and at discharge are displayed in Table 3. Subsequent to
admission, rates of hypophosphatemia, hypocalcemia,
hyponatremia, hypokalemia, and hypomagnesaemia were
47.3 % (n = 61), 43.4 % (n = 56), 18.6 % (n = 24), 12.4 %
(n = 16), and 1.6 % (n = 2), respectively. a Participant age,
sex, rates of caloric or %mBMI change, or admission
%mBMI were not significant predictors of hypophospha-
temia during hospitalization (adjusting for length of
stay). No participants evidenced hypophosphatemia at
discharge, although 100 patients (77.5 %) were pre-
scribed phosphorus supplements at discharge. Of the pa-
tients for whom the discharge phosphorus dose was
available (n = 98), the mean dose was 1012.76 mg (SD =
611.71; range: 250–3000 mg). Despite the significant
number of participants evidencing risk for refeeding
syndrome during treatment, both chart review and
quantitative assessment of refeeding criteria (i.e. hypo-
phosphatemia, hypokalemia, and hypomagnesemia, each
at some point during hospitalization) did not identify
any cases of full refeeding syndrome.
Other medications prescribed to patients are shown in
Table 4. With respect to psychotropic medications, a
substantial proportion of patients (n = 57; 44.2 %) were
prescribed antidepressants (i.e., fluoxetine, amitriptyline,
citalopram, escitalopram), while a smaller number were
prescribed atypical antipsychotic medication (n = 6; 4.7 %).
Changes in calories
The majority of patients (89.9 %) were started on
1500 kcal meal plans upon admission, and on average,
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participants increased to over 3600 kcal by day 14. The
mean prescribed calorie level at discharge (i.e., approxi-
mately 3771 kcal) represented over 150 % of partici-
pants’ EER (Table 2). As shown in Table 2, there was a
mean increase of 163.87 kcal per day.
Changes in weight and %mBMI
Participants evidenced a mean weekly weight gain of
1.39 kg (SD = 1.49). Table 5 displays results of growth
curve analyses estimating changes in %mBMI. As
displayed in Fig. 1, results indicated an average linear
increase of 0.43 in %mBMI per day from the time of ad-
mission to follow-up, with the quadratic slope estimate
indicating a significant deceleration over time (Table 5,
Model 1). However, when considering only the time dur-
ing hospitalization, there was not significant acceleration
or deceleration in growth (Model 2), suggesting a linear
change during hospitalization.
The piecewise growth model (Model 3) indicated that
participants increased an average of 0.38 per day in
%mBMI during hospitalization compared to 0.09 per day
between the time of discharge and follow-up (Fig. 2),
with both slopes being significantly greater than zero.
Predictors of %mBMI
As indicated by results of conditional models [4, 5],
younger participants evidenced lower initial %mBMI.
Higher rates of caloric increases were associated with
greater increases in %mBMI during but not after
hospitalization (Models 4–5). The number of calories
prescribed at discharge was not related to change in
%mBMI post-hospitalization (Model 5). A Bernoulli
model (Model 6) estimating the probability of re-
hospitalization after discharge found that neither the
rate of caloric change (OR: .99; CI: .98–1.00) nor rate of
%mBMI change (OR: .22; CI: .01–6.06) was associated
Table 2 Descriptive statistics
N Min Max M SD
Length of stay (days) 129 0.88 40.01 14.98 7.51
Participant age 129 10.04 22.94 15.84 2.37
Admission initial calories 129 1500.00 3000.00 1585.27 280.37
Day 14 prescribed calories 71 1500.00 5000.00 3626.17 644.68
Discharge calories 129 1500.00 5000.00 3771.32 829.17
Admission initial calories % of EER 129 29.02 131.32 64.52 14.34
Discharge calories % of EER 129 59.00 230.08 152.81 37.43
Admission to discharge calorie change 129 0.00 3500.00 2186.05 875.16
Calorie change (admission to discharge) % of EER 129 0.00 238.61 130.21 52.46
Admission %mBMI 124 61.51 110.64 79.40 8.47
Discharge %mBMI 124 64.40 111.18 85.54 8.11
Four-week follow-up %mBMI 74 72.07 113.70 89.84 7.92
Admission BMI 129 11.90 20.60 15.86 1.81
Discharge BMI 129 13.70 21.40 17.12 1.62
Days between discharge and follow-up 83 21.00 44.00 26.07 5.59
Days on telemetry 127 0.00 14.00 2.84 2.18
Days administered (IV) fluids 11 1.00 2.00 1.18 0.40
Fluid balance day 1(mL) 127 −4070.00 2818.00 −431.59 945.97
Fluid balance day 2 (mL) 126 −6005.00 1570.00 −733.80 1079.87
Fluid balance day 3 (mL) 122 −5125.00 1920.00 −480.36 1015.64
Rate of calorie change (kcal/day)
Admission to discharge 129 0.00 539.12 163.87 72.65
Week 1 (Day 1–7) 116 −14.29 457.14 185.16 82.57
Week 2 (Day 7–14) 70 −123.81 300.00 120.48 76.66
Week 3 (Day 14–21) 28 −250.00 200.00 1.33 113.07
Week 4 (Day 21–28) 9 −100.00 392.86 80.95 136.59
%mBMI Percentage of median BMI, EER Estimated Energy Requirement, BMI Body Mass Index
%mBMI was not calculated for individuals over 20 years of age (n = 6) due to upper limits of the Center for Disease Control (CDC) BMI-for-age percentile charts
Fluid balance was calculated as total input minus total output
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with re-hospitalization. Exploratory analyses revealed
that the rate of caloric change was not correlated with
the number of meal replacements administered (Spear-
man’s ρ =−.11, p = .345) or number of incidences of food
refusal (ρ = .13, p = .492) during hospitalization.
Notably, three participants (2.33 %) evidenced de-
creases in %mBMI between admission and discharge.
Compared to the rest of the sample, these individuals
had significantly shorter lengths of stay (M = 1.89 days,
SD = 1.03, t[120] =−15.04, p = <.001), lower calories (in
relationship to their EER) prescribed at discharge
(t[120] =−3.26, p = .001), yet the rate of caloric change
did not differ significantly between groups (t[120] = .84,
p = .491). Chart review of these cases found that these
participants left prematurely against recommendations
of the treatment team.
Discussion
The present study aimed to assess the safety and effect-
iveness of a more accelerated refeeding protocol for hos-
pitalized youth with AN and atypical AN. This protocol
was largely consistent with the “start high, advance fast”
approach [34], as evidenced in this sample by (1) a mean
weight gain of approximately 1.4 kg per week; (2)
medical stabilization for discharge within 15 days; and
(3) a mean caloric increase of 164 kcal per day, which
exceeded 3600 kcal by day 14. In addition, this proto-
col was able to be implemented with exclusively oral
intake, with a small number of participants receiving
NJ/NG tube feedings (n = 11) who were excluded
from analyses.
Consistent with previous literature [16], youth with
AN and atypical AN were able to tolerate more ag-
gressive refeeding during hospitalization without any
occurrences of refeeding syndrome. However, there
was a significant risk of refeeding syndrome during
hospitalization, as evidenced by hypophosphatemia in
Table 3 Laboratory values at admission, during treatment, and discharge



















Test Reference range N M SD N % N % N % N % N M SD N % N %
Sodium 137–147 mEq/L 129 139.39 2.49 15 11.63 0 0 24 18.60 1 0.78 126 140.21 1.77 0 0 0 0
BUN Age < 18: 9–18 mg/dL 129 14.57 5.62 13 10.08 24 18.60 28 21.71 40 31.01 126 14.36 4.13 7 5.43 14 10.85
Age >18: 8–22 mg/dL
Potassium 3.5–5.3 mEq/L 129 3.87 0.37 11 8.53 0 0 16 12.40 2 1.55 126 4.15 0.30 0 0 0 0
Glucose 70–100 mg/dL 129 81.62 18.64 34 26.36 20 15.50 54 41.86 11 8.53 126 82.11 9.60 10 7.75 5 3.88
Calcium 8.6–10.6 mg/dL 129 6.65 2.30 69 53.49 0 0 56 43.41 0 0.00 126 6.61 2.28 72 55.81 0 0
Phosphorus 3.0–5.5 mg/dL 129 3.63 0.58 13 10.07 0 0 61 47.28 9 6.98 125 4.34 0.57 0 0 3 2.33
Magnesium 1.5–2.5 mg/dL 126 1.87 0.23 2 1.55 0 0 2 1.55 1 0.78 126 1.84 0.23 1 0.78 0 0
Chloride 98–106 mEq/L 129 103.84 3.16 5 3.88 24 19 6 4.65 74 57.36 126 105.10 2.46 0 0 31 24.03
Creatinine 0.38–0.99 mg/dL 129 0.77 0.16 0 0 15 11.63 0 0 14 10.85 125 0.68 0.14 0 0 4 3.10
AST a 10–41 U/L 110 27.70 40.37 1 0.78 9 6.98
ALT a 30–65 U/L 110 43.32 68.15 45 34.88 9 6.98
Albumin a 3.5–5.0 g/dL 119 4.30 0.46 4 3.10 5 3.88
Protein a 6.0–8.0 g/dL 110 7.43 0.61 1 0.78 15 11.63
WBC a 4.5–13 K/UL 115 5.45 1.54 32 24.81 0 0
TSH a .5–4.8 ulU/mL 103 1.81 1.49 9 6.98 5 3.88
Prealbumin a 21.2–42.4 mg/dL 37 22.08 5.36 17 13.18 0 0
a Not repeated during treatment or at discharge
Table 4 Summary of medications prescribed to patients
Medication n %
Hydroxyzine 64 49.61
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47.3 % of participants. Nevertheless, while the proportion
of participants who evidenced hypophosphatemia in this
study was comparable to that observed in previous research
[25], it appears more participants were prescribed phos-
phorus supplements in this study compared to others
[25, 28]. It is important to note that electrolytes were
monitored closely during treatment with aggressive
phosphorus supplementation, which likely helped to
prevent progression to refeeding syndrome.
In line with Golden and colleagues [26], hypophospha-
temia was unrelated to caloric or %mBMI changes.
Admission weight was not related to hypophosphatemia
in this study, which is contrary to previous research
demonstrating a relationship between the degree of mal-
nutrition and hypophosphatemia [15, 45]. It is not clear
why this was observed in the present sample, as partici-
pants evidenced similar admission %mBMI compared to
other research [25]. One possible explanation is that
Table 5 Summary of growth curve model results
Dependent variable Independent variables Estimate SE t p
1. %mBMI change Intercept 79.36 0.78 101.17 <0.001
from admission Time 0.43 0.02 17.43 <0.001
to follow-up Time2 <0.01 <0.01 −7.55 <0.001
2. %mBMI change Intercept 79.39 0.75 105.18 <0.001
during Hospital time 0.37 0.09 4.38 <0.001
hospitalization Hospital time2 <0.01 <0.01 0.59 0.558
3. %mBMI change during Intercept 79.40 0.79 100.48 <0.001
hospitalization vs. Hospitalization time 0.38 0.02 17.85 <0.001
post-hospitalization Post-hospitalization time 0.09 0.01 6.56 <0.001
Conditional models
4. %mBMI change Intercept 79.28 1.02 77.66 <0.001
during Age −0.99 0.36 −2.72 0.007
hospitalization Calorie rate 0.04 0.01 3.03 0.003
Age −0.01 0.01 −2.08 0.038
EER <0.01 <0.01 0.48 0.632
Time (hospitalization) 0.29 0.01 54.7 <0.001
5. %mBMI change Intercept 87.37 2.80 31.25 <0.001
post-hospitalization Age −1.55 0.52 −2.97 0.004
Calorie rate <0.01 <0.01 −0.10 0.924
Age <0.01 0.01 −2.08 0.041
EER <0.01 <0.01 0.69 0.493
Discharge calories <0.01 <0.01 −1.67 0.099
Age <0.01 <0.01 1.49 0.141
EER <0.01 <0.01 −1.15 0.255
Time (post-hospitalization) 0.08 0.11 0.70 0.489
6. Probability of re- Intercept −2.33 0.35 −6.65 <0.001
admission Age −0.19 0.17 −1.10 0.273
Discharge %mBMI 0.05 0.04 1.05 0.296
Age −0.01 0.02 −0.53 0.597
%mBMI rate −1.50 1.67 −0.90 0.371
Age 2.03 1.05 1.94 0.055
Calorie rate −0.01 0.01 −1.70 0.092
Age <0.01 <0.01 −0.75 0.452
EER <0.01 <0.01 −1.23 0.222
Time was scaled for hospitalization days or post-hospitalization days according to the specified model
EER estimated energy requirement, %mBMI percentage of median BMI
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preventative phosphorus supplementation for all patients
who evidenced low or declining phosphorus values ne-
gated differences between patients with lower and higher
%mBMI at admission. Furthermore, as noted by the re-
cent position statement of the Society for Adolescent
Health and Medicine [15], refeeding hypophosphatemia
may present at any weight after a period of malnutrition.
The present study also did not assess the degree of
weight loss prior to hospitalization, which has been
shown to be predictive of hypophosphatemia during
treatment [26]. This may have occurred in the present
sample, and it would be useful for future studies to explore
this risk factor. Thus, while the current study did not dem-
onstrate a relationship between hypophosphatemia and
%mBMI at admission, given the prophylactic phosphorus
supplementation, findings do not discount the need for
medical providers to be cautious of the risk of hypopho-
sphatemia in severely malnourished patients [15].
This was one of few studies to include a post-
hospitalization assessment of a more aggressive refeed-
ing protocol. Both caloric and %mBMI changes were
greatest early on during hospitalization; not surprisingly,
%mBMI change was greater during hospitalization com-
pared to post-hospitalization. Nevertheless, participants
continued to demonstrate significant increases in
%mBMI after discharge, during which time they were
engaged in outpatient therapies that supported continued
weight gain. While previous studies have not specifically
assessed the rate of caloric change, the present results sug-
gested that higher rates of caloric increases were related to
greater increases in %mBMI during but not after
hospitalization. Thus, in addition to the existing support
for starting at higher initial caloric levels [25, 26], these
findings describe the specific relationship between rate of
caloric change and degree of weight change during
hospitalization. It is also notable that the rate of caloric
change or number of calories prescribed at discharge were
not predictive of post-hospitalization changes in %mBMI.
Taken together, it may be that other factors (e.g., out-
patient treatment) are more influential in the rate of
weight gain post-hospitalization. Of note, both of the out-
patient treatments (i.e., FBT and CBT-E) were structured
evidenced-based protocols that have demonstrated effect-
iveness in facilitating weight gain in AN, and these specific
treatments may have contributed to the observed post-
hospitalization weight gain, which is consist with previous
research [32]. Thus, it would be beneficial for future study
to assess additional variables post-hospitalization that may
facilitate early response and weight gain, which has been
shown to predict long-term outcome in AN [46].
As hypothesized, higher rates of caloric and %mBMI
increases were not related to an increased likelihood of
re-hospitalization after discharge. These results replicate
previous findings [25, 26], and may suggest that imple-
mentation of more accelerated refeeding protocols could
result in shorter hospital stays and reduce cost and bur-
den to patients and families. Furthermore, there is evi-
dence to show that shorter lengths of stay followed by
outpatient treatment are not detrimental to long-term
physical or psychological outcomes in AN [32]. This is
important to consider in light of the rising trend of resi-
dential treatments for eating disorders [47] and high cost
of inpatient hospitalization [4, 48]. Brief inpatient med-
ical stabilization in conjunction with evidence-based out-
patient care may prove vastly more cost-effective and
efficacious in outcome compared to prolonged inpatient
and residential treatments, though further research is
necessary to demonstrate these effects.
Limitations
There were several limitations to this study. There was
not a lower-calorie comparison group, which would have
Fig. 1 Displays the curvilinear change in %mBMI between admission
and follow-up. 1The mean length of stay (14.98 days) and mean days
between discharge and follow-up (26.07 days) were summed to
determine the range of values for the x-axis. Follow-up data
points represented only patients who completed this assessment
Fig. 2 Changes in mean percentage of median BMI (%mBMI) during
and after hospitalization. Figure 2 displays the results of the piecewise
growth model illustrating the differing rates of change in %mBMI
during and after hospitalization. 1The mean length of stay (14.98 days)
and mean days between discharge and follow-up (26.07) were
summed to determine the range of values for the x-axis. Follow-up
data points represented only patients who completed this assessment
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allowed for comparisons in %mBMI change and inci-
dence of hypophosphatemia. The timing of caloric in-
creases was not possible to assess, which would be
helpful for future studies to address. The sample in-
cluded only the first inpatient admission for youth with
AN, and it is unclear whether this protocol would be
similarly effective for other diagnoses, adults, or for
more chronically ill patients. This study did not include
measures of psychological symptoms that could assess
changes in distress; however, it is notable there was not
a significant relationship between caloric rate and meal
replacements or food refusal, which suggests that higher
caloric increases were tolerated. Re-admission beyond
4 weeks after discharge was not assessed; while there
were no significant differences in many characteristics
between those who completed the follow-up assessment
and those who did not, it is unclear whether the latter
group evidenced similar improvement in %mBMI after
discharge. Participants who completed the follow-up as-
sessment were also engaged in structured therapies,
which makes it difficult to distinguish effects of the
refeeding protocol compared to those of post-
hospitalization treatment. Moreover, the types of post-
hospitalization treatment (i.e., FBT vs. CBT-E) were not
assessed as a potential moderators of post-hospital
weight gain or re-admission, and future research is
needed to assess whether these outcomes vary according
to treatment type.
Conclusions
Despite the aforementioned limitations, this study dem-
onstrated youth with AN and atypical AN can tolerate
more accelerated oral refeeding protocols without incur-
ring refeeding syndrome. In particular, this study adds to
the literature by describing the specific relationship
between of the rate of caloric advances and weight
changes during hospitalization. Although results lend
preliminary support for more rapid caloric advances,
additional research is necessary to assess long-term
outcomes of such approaches, as well as investigate
whether such approaches are feasible in settings
outside the hospital. However, these results also
underscore the importance of vigilant monitoring of
indicators of refeeding syndrome, and treatment pro-
viders must be prepared to intervene with electrolyte
correction. In sum, results suggest that the “starting
higher, advancing faster” approach can possibly facili-
tate more cost-effective treatment, yet findings also
underscore the importance of having available and
accessible evidence-based outpatient treatments. Contin-
ued work is also needed to standardize the implementa-
tion of “starting higher, advancing faster” approaches for
broader dissemination.
Endnotes
1Atypical AN was defined as %mBMI > 89 %. For
participants for whom %mBMI could not be calculated
because their age exceeded the maximum age specified
in CDC BMI-for-age charts, atypical AN was defined as
BMI >17.5.
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